ECHO Management Committee on New WHO Guidance on Use of Hormonal Contraceptives by Women at High Risk of HIV

ECHO Management Committee on New WHO Guidance on Use of Hormonal Contraceptives by Women at High Risk of HIV Statement by the ECHO Management Committee on the new WHO guidance on use of hormonal contraceptives by women at high risk of HIV.       ...

ECHO Trial Protocol

ECHO Trial Protocol Protocol for “A Multi Center, Open-Label, Randomised Clinical Trial Comparing HIV Incidence and Contraceptive Benefits in Women using Depot Medroxyprogesterone Acetate (DMPA), Levonorgestrel (LNG) Implant, and Copper Intrauterine Devices...

Hormonal Contraceptives and HIV – An Introductory Fact Sheet

Hormonal Contraceptives and HIV – An Introductory Fact Sheet Information on hormonal contraceptive methods, their impact on HIV risk in HIV-negative women, and their use in women living with HIV.       Published: 2017 Source: AVAC Back to...

What Is Up with DMPA and “Grades” for Family Planning?

What Is Up with DMPA and “Grades” for Family Planning? AVAC’s sheet on the hormonal contraceptive known as Depo-Provera (DMPA) and the WHO grading system for contraceptives explains key issues in plain language. Research findings have raised questions about the...

FAQs: Hormonal Contraceptive Eligibility for Women at High Risk of HIV

Hormonal Contraceptive Eligibility for Women at High Risk of HIV, Frequently Asked Questions, WHO, Feb. 2017 Hormonal contraceptive eligibility for women at high risk of HIV, Frequently asked questions and responses.       Published: 2017 Source: WHO...